Genetic differences in metabolism of polycyclic aromatic carcinogens and aromatic amines by mouse liver microsomes. Detection by DNA binding of metabolites and by mutagenicity in histidine-dependent Salmonella typhimurium in vitro

Roy C Levitt, O. Pelkonen, A. B. Okey, D. W. Nebert

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The metabolism of various carcinogens and other chemicals by genetically regulated increases in cytochrome P1-450 content was studied with the use of liver from 3-methylcholanthrene (MCA)-treated C57BL/6N and DBA/2N mice. ['P1-450' is defined as that form(s) of cytochrome that increases during polycyclic aromatic inducer treatment of the laboratory animal or cells in culture. Two forms of P1-450 have been characterized electrophoretically and catalytically, and even more than two are believed to exist]. Genetic differences were seen in the DNA binding of metabolites in vitro for: dibenz[a,h]anthracene, benz[a]anthracene, benzo[a]pyrene (BP), MCA, 7,12-dimethylbenz[a]anthracene, 2-acetylaminofluorene, and dopamine (approximately in descending order). Any difference for dibenz[a,c]anthracene or benzidine was very small. Marked genetic differences were observed in the mutagenicity (with Salmonella typhimurium tester strains TA1538, TA98, or TA100) in vitro for: 6-aminochrysene, dibenz[a,h]anthracene, dibenz[a,c]anthracene, β-naphthylamine, MCA, 2-acetylaminofluorene, BP, benz[a]anthracene, and α-naphthylamine (approximately in descending order); the difference for 7,12-dimethylbenz[a]anthracene was very small. Important discrepancies for certain carcinogens therefore existed between genetic differences in metabolites binding to DNA and genetic differences in the metabolites causing mutation in this bacterial in vitro assay. These data may be useful for future studies with any of these chemicals in the extrapolation of genetic differences observed in vitro to differences in the risk of cancer associated with the Ah locus in the intact animal. Such genetic data for MCA and BPO tumorigenesis have already been helpful in understanding the mechanism of chemical carcinogenesis.

Original languageEnglish
Pages (from-to)947-955
Number of pages9
JournalJournal of the National Cancer Institute
Volume62
Issue number4
StatePublished - Dec 1 1979
Externally publishedYes

Fingerprint

Methylcholanthrene
Liver Microsomes
Salmonella typhimurium
Histidine
Carcinogens
Amines
2-Acetylaminofluorene
DNA
Cytochromes
Carcinogenesis
Inbred DBA Mouse
Benzo(a)pyrene
Laboratory Animals
Dopamine
Cell Culture Techniques
Mutation
In Vitro Techniques
Liver
Neoplasms
benz(a)anthracene

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

@article{25d02950ccdb46ac8665325e526aa274,
title = "Genetic differences in metabolism of polycyclic aromatic carcinogens and aromatic amines by mouse liver microsomes. Detection by DNA binding of metabolites and by mutagenicity in histidine-dependent Salmonella typhimurium in vitro",
abstract = "The metabolism of various carcinogens and other chemicals by genetically regulated increases in cytochrome P1-450 content was studied with the use of liver from 3-methylcholanthrene (MCA)-treated C57BL/6N and DBA/2N mice. ['P1-450' is defined as that form(s) of cytochrome that increases during polycyclic aromatic inducer treatment of the laboratory animal or cells in culture. Two forms of P1-450 have been characterized electrophoretically and catalytically, and even more than two are believed to exist]. Genetic differences were seen in the DNA binding of metabolites in vitro for: dibenz[a,h]anthracene, benz[a]anthracene, benzo[a]pyrene (BP), MCA, 7,12-dimethylbenz[a]anthracene, 2-acetylaminofluorene, and dopamine (approximately in descending order). Any difference for dibenz[a,c]anthracene or benzidine was very small. Marked genetic differences were observed in the mutagenicity (with Salmonella typhimurium tester strains TA1538, TA98, or TA100) in vitro for: 6-aminochrysene, dibenz[a,h]anthracene, dibenz[a,c]anthracene, β-naphthylamine, MCA, 2-acetylaminofluorene, BP, benz[a]anthracene, and α-naphthylamine (approximately in descending order); the difference for 7,12-dimethylbenz[a]anthracene was very small. Important discrepancies for certain carcinogens therefore existed between genetic differences in metabolites binding to DNA and genetic differences in the metabolites causing mutation in this bacterial in vitro assay. These data may be useful for future studies with any of these chemicals in the extrapolation of genetic differences observed in vitro to differences in the risk of cancer associated with the Ah locus in the intact animal. Such genetic data for MCA and BPO tumorigenesis have already been helpful in understanding the mechanism of chemical carcinogenesis.",
author = "Levitt, {Roy C} and O. Pelkonen and Okey, {A. B.} and Nebert, {D. W.}",
year = "1979",
month = "12",
day = "1",
language = "English",
volume = "62",
pages = "947--955",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Genetic differences in metabolism of polycyclic aromatic carcinogens and aromatic amines by mouse liver microsomes. Detection by DNA binding of metabolites and by mutagenicity in histidine-dependent Salmonella typhimurium in vitro

AU - Levitt, Roy C

AU - Pelkonen, O.

AU - Okey, A. B.

AU - Nebert, D. W.

PY - 1979/12/1

Y1 - 1979/12/1

N2 - The metabolism of various carcinogens and other chemicals by genetically regulated increases in cytochrome P1-450 content was studied with the use of liver from 3-methylcholanthrene (MCA)-treated C57BL/6N and DBA/2N mice. ['P1-450' is defined as that form(s) of cytochrome that increases during polycyclic aromatic inducer treatment of the laboratory animal or cells in culture. Two forms of P1-450 have been characterized electrophoretically and catalytically, and even more than two are believed to exist]. Genetic differences were seen in the DNA binding of metabolites in vitro for: dibenz[a,h]anthracene, benz[a]anthracene, benzo[a]pyrene (BP), MCA, 7,12-dimethylbenz[a]anthracene, 2-acetylaminofluorene, and dopamine (approximately in descending order). Any difference for dibenz[a,c]anthracene or benzidine was very small. Marked genetic differences were observed in the mutagenicity (with Salmonella typhimurium tester strains TA1538, TA98, or TA100) in vitro for: 6-aminochrysene, dibenz[a,h]anthracene, dibenz[a,c]anthracene, β-naphthylamine, MCA, 2-acetylaminofluorene, BP, benz[a]anthracene, and α-naphthylamine (approximately in descending order); the difference for 7,12-dimethylbenz[a]anthracene was very small. Important discrepancies for certain carcinogens therefore existed between genetic differences in metabolites binding to DNA and genetic differences in the metabolites causing mutation in this bacterial in vitro assay. These data may be useful for future studies with any of these chemicals in the extrapolation of genetic differences observed in vitro to differences in the risk of cancer associated with the Ah locus in the intact animal. Such genetic data for MCA and BPO tumorigenesis have already been helpful in understanding the mechanism of chemical carcinogenesis.

AB - The metabolism of various carcinogens and other chemicals by genetically regulated increases in cytochrome P1-450 content was studied with the use of liver from 3-methylcholanthrene (MCA)-treated C57BL/6N and DBA/2N mice. ['P1-450' is defined as that form(s) of cytochrome that increases during polycyclic aromatic inducer treatment of the laboratory animal or cells in culture. Two forms of P1-450 have been characterized electrophoretically and catalytically, and even more than two are believed to exist]. Genetic differences were seen in the DNA binding of metabolites in vitro for: dibenz[a,h]anthracene, benz[a]anthracene, benzo[a]pyrene (BP), MCA, 7,12-dimethylbenz[a]anthracene, 2-acetylaminofluorene, and dopamine (approximately in descending order). Any difference for dibenz[a,c]anthracene or benzidine was very small. Marked genetic differences were observed in the mutagenicity (with Salmonella typhimurium tester strains TA1538, TA98, or TA100) in vitro for: 6-aminochrysene, dibenz[a,h]anthracene, dibenz[a,c]anthracene, β-naphthylamine, MCA, 2-acetylaminofluorene, BP, benz[a]anthracene, and α-naphthylamine (approximately in descending order); the difference for 7,12-dimethylbenz[a]anthracene was very small. Important discrepancies for certain carcinogens therefore existed between genetic differences in metabolites binding to DNA and genetic differences in the metabolites causing mutation in this bacterial in vitro assay. These data may be useful for future studies with any of these chemicals in the extrapolation of genetic differences observed in vitro to differences in the risk of cancer associated with the Ah locus in the intact animal. Such genetic data for MCA and BPO tumorigenesis have already been helpful in understanding the mechanism of chemical carcinogenesis.

UR - http://www.scopus.com/inward/record.url?scp=0018743832&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018743832&partnerID=8YFLogxK

M3 - Article

C2 - 372661

AN - SCOPUS:0018743832

VL - 62

SP - 947

EP - 955

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 4

ER -